10 free, board-style Gastrointestinal questions for the PANRE, each with the correct answer and a complete explanation. No email, no account required.
Gastrointestinal is 10% of the PANRE content blueprint. These questions come from the clinician-reviewed FirstPassPA bank. Attempt each one before you reveal the answer.
Question 1GastrointestinalMedium
A 65-year-old man with cirrhosis and ascites is admitted with diffuse abdominal pain, fever, and worsening confusion. Diagnostic paracentesis shows an ascitic fluid polymorphonuclear (PMN) count of 350 cells/mm3. Which of the following is the most appropriate initial treatment?
AOral ciprofloxacin
BTherapeutic paracentesis
CIntravenous gentamicin
DIntravenous vancomycin
EIntravenous cefotaxime
Reveal answer & full explanation
Correct answer: E — Intravenous cefotaxime
AOral ciprofloxacin
BTherapeutic paracentesis
CIntravenous gentamicin
DIntravenous vancomycin
EIntravenous cefotaxime✓
Why Intravenous cefotaxime is correct
An ascitic fluid PMN count of at least 250 cells/mm3 establishes spontaneous bacterial peritonitis (SBP), and empiric antibiotics are started immediately without waiting for culture (cultures are negative in roughly half of cases)
A third-generation cephalosporin such as intravenous cefotaxime is first-line therapy; intravenous albumin is added to reduce the risk of hepatorenal syndrome and death
Why the others are wrong
Intravenous vancomycin — covers gram-positive organisms only and misses the enteric gram-negative bacilli, chiefly Escherichia coli and Klebsiella, that cause most SBP, so it is inadequate empiric coverage (reflex broad-spectrum antibiotic)
Oral ciprofloxacin — an oral fluoroquinolone is used for SBP prophylaxis or uncomplicated cases, not for an acute episode with encephalopathy and systemic signs, where intravenous therapy is required (confused-with-prophylaxis)
Therapeutic paracentesis — large-volume paracentesis treats tense ascites, not the infection, and does nothing for the bacterial peritonitis (right-setting-wrong-target)
Intravenous gentamicin — an aminoglycoside covers the enteric gram-negative bacilli that cause most SBP, but it is avoided in cirrhosis because its nephrotoxicity adds to the already high risk of acute kidney injury and hepatorenal syndrome that accompanies SBP (right-spectrum-wrong-patient)
Question 2GastrointestinalMedium
A 32-year-old man reports 3 months of sharp pain with defecation and bright red blood on the toilet paper. He has a history of chronic constipation and strains during bowel movements. On exam, gentle external traction reveals a longitudinal tear in the posterior midline of the anal canal with a small sentinel skin tag. He has been managing with sitz baths, increased fiber, and topical nifedipine, but symptoms have not resolved. Which of the following is the most likely diagnosis?
AInternal hemorrhoids
BCrohn-associated anal fissure
CChronic anal fissure
DAcute anal fissure
EAnal fistula
Reveal answer & full explanation
Correct answer: C — Chronic anal fissure
AInternal hemorrhoids
BCrohn-associated anal fissure
CChronic anal fissure✓
DAcute anal fissure
EAnal fistula
Why Chronic anal fissure is correct
An acute anal fissure that persists beyond 6–8 weeks despite conservative therapy progresses to a chronic fissure.
Chronic fissure is characterized by a sentinel skin tag externally, a hypertrophied anal papilla internally, and exposure of internal sphincter fibers at the base.
Chronicity results from a hypertonic internal anal sphincter that perpetuates ischemia of the fissure bed.
Why the others are wrong
Acute anal fissure — an acute fissure lasts less than 6–8 weeks, has no sentinel skin tag, and heals with the fiber, sitz baths, and topical nifedipine that have already failed over 3 months here.
Anal fistula — typically follows drainage of a cryptoglandular abscess and presents with chronic purulent drainage, not pain with defecation.
Crohn-associated anal fissure — Crohn fissures are typically lateral, multiple, deep, or relatively painless and travel with diarrhea, weight loss, or perianal fistulizing disease, rather than an isolated posterior-midline tear from chronic straining.
Internal hemorrhoids — shares the constipation, straining, and bright red blood on the toilet paper, and the sentinel tag can be mistaken for hemorrhoidal tissue, but uncomplicated internal hemorrhoids arise above the dentate line and bleed painlessly; sharp pain with defecation and a visible posterior-midline tear identify a fissure.
Additional high-yield points
When chronic fissure fails medical therapy, lateral internal sphincterotomy is the surgical gold standard.
Question 3GastrointestinalEasy
A 50-year-old man develops diarrhea with 8 stools daily, 5 days after completing a course of clindamycin for a dental abscess. He is hemodynamically stable, with a normal WBC and creatinine. Stool Clostridioides difficile toxin PCR is positive. Which of the following is the most appropriate first-line treatment?
AIntravenous vancomycin
BOral metronidazole
CIntravenous metronidazole
DFecal microbiota transplantation
EOral vancomycin
Reveal answer & full explanation
Correct answer: E — Oral vancomycin
AIntravenous vancomycin
BOral metronidazole
CIntravenous metronidazole
DFecal microbiota transplantation
EOral vancomycin✓
Why Oral vancomycin is correct
For an initial episode of Clostridioides difficile infection (CDI), current IDSA/SHEA guidance recommends oral vancomycin or oral fidaxomicin as first-line therapy for 10 days
This patient has a clear precipitant (recent clindamycin) and a positive toxin PCR with non-severe disease (hemodynamically stable, normal WBC and creatinine), so a 10-day oral vancomycin course is appropriate
Oral vancomycin is minimally absorbed and acts locally in the colonic lumen, which is why the oral route is required for CDI
Why the others are wrong
Intravenous metronidazole — reserved as an adjunct for fulminant CDI (ileus or toxic megacolon), not initial non-severe disease; this stable patient with a normal WBC does not meet that threshold (confused-with-fulminant-regimen)
Fecal microbiota transplantation — reserved for multiply recurrent CDI, not an initial episode (right-therapy-wrong-stage)
Oral metronidazole — downgraded from first-line because of inferior cure rates compared with vancomycin and fidaxomicin (premature closure on the old first-line drug)
Intravenous vancomycin — vancomycin is the right drug, but given intravenously it reaches only negligible concentrations in the colonic lumen, so it does not treat CDI; for this patient it must be given orally (right-drug-wrong-route)
Question 4GastrointestinalMedium
A 40-year-old man with newly biopsy-confirmed celiac disease is started on a gluten-free diet. He reports several months of fatigue. Which of the following is the most important additional step to take at the time of diagnosis?
ARepeat small bowel biopsy at 1 month
BObtain HLA-DQ2/DQ8 genotyping
CScreen for nutritional deficiencies
DEvaluate for intestinal lymphoma
EInitiate systemic corticosteroids
Reveal answer & full explanation
Correct answer: C — Screen for nutritional deficiencies
ARepeat small bowel biopsy at 1 month
BObtain HLA-DQ2/DQ8 genotyping
CScreen for nutritional deficiencies✓
DEvaluate for intestinal lymphoma
EInitiate systemic corticosteroids
Why Screen for nutritional deficiencies is correct
Celiac disease damages the proximal small bowel, where iron, folate, calcium, and fat-soluble vitamins are absorbed, so newly diagnosed patients should be screened for deficiencies at diagnosis
Iron-deficiency anemia is the most common finding and explains this patient's fatigue; folate, vitamin B12, vitamin D, zinc, and copper should also be checked, and a baseline DEXA scan is recommended because malabsorption predisposes to osteoporosis
Screening for and replacing deficiencies at diagnosis, alongside the gluten-free diet, is consistent with current ACG guidance and is what reverses the systemic consequences of malabsorption
Why the others are wrong
Obtain HLA-DQ2/DQ8 genotyping — HLA typing is used to exclude celiac disease when the diagnosis is uncertain or when a patient is already gluten-free; it adds nothing once biopsy has confirmed disease and does nothing for his malabsorption (buzzword-matching celiac to its genetic marker)
Initiate systemic corticosteroids — Steroids are reserved for refractory celiac disease or celiac crisis, not initial management, which is dietary gluten withdrawal (right-disease-wrong-treatment)
Repeat small bowel biopsy at 1 month — Mucosal healing takes months to years; response is monitored with anti-tissue transglutaminase IgA at 6-12 months, so a 1-month rebiopsy is premature and low-yield (premature closure on early re-testing)
Evaluate for intestinal lymphoma — enteropathy-associated T-cell lymphoma is a recognized complication of celiac disease, and fatigue can raise concern for malignancy, but lymphoma is pursued when symptoms persist or alarm features such as new weight loss, fever, or abdominal pain develop despite strict gluten avoidance, not screened for routinely at diagnosis; his fatigue is far more likely to reflect iron deficiency (anchoring on a rare complication)
Question 5GastrointestinalMedium
A 62-year-old woman with primary biliary cholangitis has been taking ursodeoxycholic acid for 2 years, with normalization of her alkaline phosphatase and bilirubin. She has no cirrhosis. Which of the following is the most important long-term monitoring step?
ARepeat antimitochondrial antibody titers
BAnnual surveillance colonoscopy
CBone density (DEXA) screening
DSemiannual abdominal CT
EAnnual variceal screening endoscopy
Reveal answer & full explanation
Correct answer: C — Bone density (DEXA) screening
ARepeat antimitochondrial antibody titers
BAnnual surveillance colonoscopy
CBone density (DEXA) screening✓
DSemiannual abdominal CT
EAnnual variceal screening endoscopy
Why Bone density (DEXA) screening is correct
Chronic cholestasis in primary biliary cholangitis impairs absorption of vitamin D and calcium, so osteoporosis is a common complication in all patients regardless of disease stage or biochemical response
Guidelines recommend a baseline DEXA scan with periodic reassessment, plus calcium and vitamin D supplementation, as standard long-term care in primary biliary cholangitis
A good biochemical response to ursodeoxycholic acid lowers progression risk but does not remove the ongoing metabolic bone risk, so monitoring still matters
Why the others are wrong
Annual variceal screening endoscopy — Endoscopic variceal surveillance is indicated only once cirrhosis or portal hypertension is established, and this patient has neither (anchoring on chronic liver disease as automatically requiring endoscopy)
Repeat antimitochondrial antibody titers — Antimitochondrial antibody establishes the diagnosis, but its titer does not track disease activity, treatment response, or complications, so serial testing changes no management (confusing a diagnostic marker with a monitoring tool)
Semiannual abdominal CT — There is no role for routine surveillance CT; HCC surveillance, only once cirrhosis is present, is done with ultrasound every 6 months, not CT (confused with the HCC surveillance modality)
Annual surveillance colonoscopy — frequent surveillance colonoscopy is the rule in primary sclerosing cholangitis with coexisting inflammatory bowel disease, which makes it tempting in any cholestatic liver disease, but primary biliary cholangitis carries no such IBD association; she needs only age-appropriate colorectal cancer screening (confusing PBC with PSC)
Question 6GastrointestinalMedium
A 72-year-old man reports several weeks of rectal bleeding and a change in bowel habits. Digital rectal examination reveals a mass, and colonoscopy shows a 4-cm tumor 6 cm from the anal verge with biopsy confirming adenocarcinoma. Pelvic MRI and staging CT demonstrate a T3N1M0 lesion with no distant metastases. Which of the following is the most appropriate initial treatment?
ASurgery then adjuvant chemoradiation
BNeoadjuvant chemoradiotherapy
CTransanal endoscopic microsurgery
DImmediate low anterior resection
ESystemic chemotherapy alone
Reveal answer & full explanation
Correct answer: B — Neoadjuvant chemoradiotherapy
ASurgery then adjuvant chemoradiation
BNeoadjuvant chemoradiotherapy✓
CTransanal endoscopic microsurgery
DImmediate low anterior resection
ESystemic chemotherapy alone
Why Neoadjuvant chemoradiotherapy is correct
This is locally advanced (stage III, T3N1M0) rectal adenocarcinoma in the mid-rectum (6 cm from the anal verge).
Standard of care is neoadjuvant (preoperative) therapy before total mesorectal excision.
Neoadjuvant chemoradiotherapy roughly halves local recurrence and can downstage the tumor to permit sphincter preservation.
Accepted regimens include long-course chemoradiation (5-FU or capecitabine with 45-54 Gy) or short-course radiotherapy.
Total neoadjuvant therapy (delivering all chemotherapy and radiation before surgery) is now preferred for most stage II-III rectal cancers; it builds on this preoperative chemoradiation (or short-course radiotherapy) and improved complete-response rates in the RAPIDO and PRODIGE 23 trials.
Why the others are wrong
Immediate low anterior resection — skips the downstaging step and yields higher local recurrence rates in node-positive disease; it is not the preferred first move for a T3N1 tumor.
Transanal endoscopic microsurgery — a local-excision technique appropriate only for early, favorable T1 lesions; it does not address nodal disease and is inadequate for a T3N1 tumor.
Systemic chemotherapy alone — FOLFOX (fluorouracil, leucovorin, oxaliplatin) is the backbone for metastatic colorectal disease and can be part of multimodal therapy, but as a standalone initial treatment it omits the surgery, and usually the radiation, this localized tumor requires.
Surgery then adjuvant chemoradiation — postoperative chemoradiation was once standard for stage II-III rectal cancer and uses the right modalities, but the German Rectal Cancer Study showed preoperative delivery lowers local recurrence and toxicity, and only preoperative therapy can downstage the tumor to permit sphincter preservation (right therapy, wrong sequence)
Question 7GastrointestinalMedium
A 65-year-old male with prior diverticulitis presents with persistent left lower quadrant pain, fever, and leukocytosis. CT shows a 5 cm pericolonic abscess adjacent to the sigmoid colon. Which of the following is the most appropriate next step in management?
AIntravenous antibiotics with serial CT imaging
BPercutaneous abscess drainage plus broad-spectrum antibiotics
CEmergent sigmoid colectomy with primary anastomosis
DOral antibiotics alone with outpatient follow-up
EUrgent colonoscopy with intravenous antibiotics
Reveal answer & full explanation
Correct answer: B — Percutaneous abscess drainage plus broad-spectrum antibiotics
AIntravenous antibiotics with serial CT imaging
BPercutaneous abscess drainage plus broad-spectrum antibiotics✓
CEmergent sigmoid colectomy with primary anastomosis
DOral antibiotics alone with outpatient follow-up
EUrgent colonoscopy with intravenous antibiotics
Why Percutaneous abscess drainage plus broad-spectrum antibiotics is correct
This patient has Hinchey stage I complicated diverticulitis (pericolonic abscess); its 5 cm size, not the Hinchey stage, is what calls for drainage
Hinchey classification: I (pericolonic abscess), II (pelvic/distant abscess), III (purulent peritonitis), IV (feculent peritonitis)
For Hinchey I–II abscesses >3–4 cm: percutaneous drainage plus IV antibiotics (ciprofloxacin/metronidazole or piperacillin-tazobactam) covering anaerobes is the standard approach
Smaller abscesses (<3–4 cm) can be treated with antibiotics alone
Why the others are wrong
Emergent sigmoid colectomy with primary anastomosis — Emergent colectomy (Hartmann procedure, or primary anastomosis with or without a diverting stoma in selected stable patients) is reserved for Hinchey III–IV (purulent or feculent peritonitis) or failed nonoperative management, not a contained abscess that can be drained
Intravenous antibiotics with serial CT imaging — Antibiotics without source control are appropriate only for abscesses smaller than 3–4 cm; a 5 cm collection is less likely to resolve on antibiotics alone, and watching it with repeat imaging prolongs sepsis and risks free perforation or fistula formation
Oral antibiotics alone with outpatient follow-up — Oral antibiotics alone are appropriate only for uncomplicated diverticulitis; small abscesses are treated with IV antibiotics, and a 5 cm abscess requires drainage
Urgent colonoscopy with intravenous antibiotics — colonoscopy is recommended after an episode of complicated diverticulitis to exclude colon cancer, but it is deferred until the acute inflammation has resolved (typically 6–8 weeks) because insufflation risks perforating the inflamed colon, and it provides no source control for a 5 cm abscess
Question 8GastrointestinalMedium
A 52-year-old man with a 30-pack-year smoking history and heavy alcohol use reports 6 months of progressive dysphagia to solids, a 20-lb weight loss, and hemoccult-positive stools. Upper endoscopy reveals an ulcerated mid-esophageal mass, and biopsy confirms squamous cell carcinoma. Staging CT shows two involved regional lymph nodes and no distant metastases. Which of the following is the most appropriate treatment?
APalliative esophageal stenting
BPrimary esophagectomy alone
CSystemic chemotherapy alone
DEndoscopic mucosal resection
EConcurrent chemoradiotherapy
Reveal answer & full explanation
Correct answer: E — Concurrent chemoradiotherapy
APalliative esophageal stenting
BPrimary esophagectomy alone
CSystemic chemotherapy alone
DEndoscopic mucosal resection
EConcurrent chemoradiotherapy✓
Why concurrent chemoradiotherapy is correct
Mid-esophageal squamous cell carcinoma with regional nodal involvement and no distant metastases is locally advanced (roughly stage II-III) and potentially curable.
Concurrent chemoradiotherapy is the standard initial treatment for locally advanced esophageal squamous cell carcinoma; for squamous histology it can be definitive, and esophagectomy may follow if the tumor remains resectable (CROSS regimen).
Smoking and alcohol are the dominant risk factors, and squamous cell carcinoma characteristically arises in the proximal-to-middle esophagus.
Why the others are wrong
Palliative esophageal stenting — Palliation is reserved for unresectable or metastatic disease; with no distant metastases the disease is potentially curable, so a stent forgoes cure (premature closure on dysphagia and weight loss).
Primary esophagectomy alone — Up-front surgery alone is inferior for node-positive disease; neoadjuvant chemoradiotherapy should precede any resection (right-disease-wrong-sequence).
Systemic chemotherapy alone — Chemotherapy alone does not provide local control for non-metastatic locally advanced disease and is reserved for metastatic disease (right-modality-wrong-setting).
Endoscopic mucosal resection — endoscopic resection can cure superficial esophageal cancer, but it is limited to node-negative disease confined to the mucosa; an ulcerated mass with two involved regional nodes needs multimodality therapy (right-procedure-wrong-stage).
Question 9GastrointestinalMedium
A 45-year-old man with ulcerative colitis involving the entire colon (pancolitis) for 15 years undergoes surveillance colonoscopy that shows mild chronic inflammation. Multiple biopsies from a flat area of the transverse colon are read as 'indefinite for dysplasia' by a single pathologist. He is maintained on mesalamine and remains clinically well. Which of the following is the most appropriate next step in management?
AProceed to colectomy
BEndoscopic resection of the flat area
CContinue annual surveillance
DIncrease mesalamine and repeat in 12 months
ERepeat colonoscopy in 3-6 months
Reveal answer & full explanation
Correct answer: E — Repeat colonoscopy in 3-6 months
AProceed to colectomy
BEndoscopic resection of the flat area
CContinue annual surveillance
DIncrease mesalamine and repeat in 12 months
ERepeat colonoscopy in 3-6 months✓
Why Repeat colonoscopy in 3-6 months is correct
'Indefinite for dysplasia' is a noncommittal pathology read with high interobserver variability, frequently driven by active inflammation; it is not itself an indication for surgery.
Per AGA/SCENIC guidance, optimize inflammation control and repeat colonoscopy in 3–6 months, ideally with chromoendoscopy and expert gastrointestinal-pathologist review, before any management change.
This confirms or refutes true dysplasia before committing the patient to a major intervention.
Why the others are wrong
Continue annual surveillance — defers reassessment far too long for an indefinite read; premature closure that under-responds to the finding.
Increase mesalamine and repeat in 12 months — controlling inflammation is reasonable, but a 12-month interval delays needed re-evaluation (right-idea-wrong-timing).
Proceed to colectomy — surgery is reserved for confirmed high-grade (or multifocal/endoscopically unresectable low-grade) dysplasia, not an unconfirmed indefinite read; anchoring on cancer risk.
Endoscopic resection of the flat area — endoscopic resection is used to remove a visible, well-demarcated lesion, but these biopsies came from flat, inflamed mucosa with no discrete lesion described, and an indefinite read has not established dysplasia; it must first be confirmed or refuted on repeat colonoscopy, ideally with chromoendoscopy, after inflammation is controlled (treating an equivocal read as confirmed dysplasia).
Question 10GastrointestinalMedium
A 50-year-old male with non-alcoholic fatty liver disease (NAFLD) cirrhosis has a 2.2 cm arterially enhancing liver lesion with washout on portal venous phase MRI. Alpha-fetoprotein (AFP) is 120 ng/mL. There is no vascular invasion. Model for End-Stage Liver Disease (MELD) is 12. Which of the following is the most likely diagnosis?
AHepatic adenoma
BCholangiocarcinoma
CMetastatic colorectal cancer
DFocal nodular hyperplasia
EHepatocellular carcinoma
Reveal answer & full explanation
Correct answer: E — Hepatocellular carcinoma
AHepatic adenoma
BCholangiocarcinoma
CMetastatic colorectal cancer
DFocal nodular hyperplasia
EHepatocellular carcinoma✓
Why hepatocellular carcinoma is correct
Arterial hyperenhancement plus washout on multiphase MRI in a cirrhotic liver meets Liver Imaging Reporting and Data System (LI-RADS) LR-5 criteria for hepatocellular carcinoma (HCC); biopsy is not required.
The 2.2 cm lesion size with preserved liver function (MELD 12) meets Milan criteria, making the patient a candidate for curative therapy: radiofrequency ablation (RFA), resection, or transplant evaluation.
Why the others are wrong
Metastatic colorectal cancer — Metastases typically show rim enhancement without washout on multiphase imaging.
Hepatic adenoma — Adenomas are uncommon in the setting of cirrhosis.
Cholangiocarcinoma — cirrhosis also raises the risk of intrahepatic cholangiocarcinoma, the main malignant mimic of HCC, but it typically shows rim arterial enhancement with progressive delayed enhancement rather than the arterial hyperenhancement with washout seen here, and it is more often associated with an elevated CA 19-9 than AFP
That's 10 of 7,700+. Get the rest.
Unlock the full FirstPassPA bank: 7,700+ board-style questions across every organ system, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
Are these Gastrointestinal PANRE practice questions free?
Yes. Each question shows the full vignette, the correct answer, and a complete explanation, with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, flashcards, and an AI tutor.
How much of the PANRE is Gastrointestinal?
Gastrointestinal makes up 10% of the PANRE content blueprint. FirstPassPA's timed PANRE exams are dealt to the same weights, so a practice exam carries the same share of Gastrointestinal questions.
How should I use these questions?
Attempt each vignette before you reveal the answer, then read the full explanation even when you got it right: the reasons each wrong choice is wrong are where most of the learning is. When you are ready for more, practice Gastrointestinal questions in the app, or take a full timed PANRE practice exam dealt to the blueprint weights.
Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.